http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107312000-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_667fdbdd2c88095f5718fc8605b0b686 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
| filingDate | 2017-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_614b62083477ae60346cba30387dbfdb |
| publicationDate | 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107312000-A |
| titleOfInvention | Preparation method of novel farnesyltransferase inhibitor with 4,5-dihydro-1,2,3-triazole structure |
| abstract | The invention discloses a preparation method of a novel farnesyl transferase inhibitor with a 4,5-dihydro-1,2,3-triazole structure, and belongs to the technical field of pharmaceutical chemical synthesis. Technical solution main points of the present invention are: Compared with the prior art, the present invention has the following beneficial effects: the synthesis method of the present invention is simple, the molecular structure is novel, and the obtained target compound has a certain inhibitory effect on breast cancer cell MCF-7, which is expected to be further popularized and applied. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107151247-A |
| priorityDate | 2017-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.